The Cancer Letter

Inside information on cancer research and drug development

In Brief

Community Oncology Alliance launches Advanced Practice Provider Network

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

THE COMMUNITY ONCOLOGY ALLIANCE launched the Advanced Practice Provider Network, for oncology nurse practitioners, physician assistants and others.

The network consists of a private, peer-to-peer-only information sharing website and listserv; monthly conference calls to review important practice issues and discuss solutions; and opportunities for in-person meetings. Participation in the network is open and free of charge to all qualified advanced practice providers. Vendors and other industry representatives are not allowed access to join this private network.

The network’s goal is to keep members up to date on the latest news and developments, such as patient support strategies; health reform initiatives; the newest drugs and therapies; and strengthening advanced provider leadership roles in practices.

The network is led and organized by advanced practice providers in community practices with technical support from COA. The co-chairs are Sarah Alexander, nurse practitioner at Lake Norman Oncology in Mooresville, N.C.; and Diana Youngs, nurse practitioner at North Shore Hematology Oncology Associates in Long Island, N.Y.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account